share_log

HC Wainwright & Co. Reiterates Buy on Arcturus Therapeutics, Maintains $51 Price Target

HC Wainwright & Co. Reiterates Buy on Arcturus Therapeutics, Maintains $51 Price Target

HC Wainwright & Co.重申買入Arcturus Therapeutics,維持51美元的目標股價
Benzinga ·  2023/11/28 07:22

HC Wainwright & Co. analyst Ed Arce reiterates Arcturus Therapeutics (NASDAQ:ARCT) with a Buy and maintains $51 price target.

HC Wainwright & Co. 分析師埃德·阿爾塞重申了Arcturus Therapeutics(納斯達克股票代碼:ARCT)的買入並維持51美元的目標股價。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論